Josh Demb retweeted
What I don't get about academia is the chronic lack of celebration. It is hard to get & maintain grant funding, hard to get papers accepted without Faustian bargains, hard to be a great mentor, & hard to maximize trainee success. All of it is hard. We should celebrate everything.
Josh Demb retweeted
🌟 COLORECTAL CANCER - Signs and symptoms for suspicion.
From : British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
gut.bmj.com/content/70/7/121…
Josh Demb retweeted
COE was proud to represent & root for our @sandiegowavefc at their #Pride2024 Night! A tough loss for us Wave fans, but it was great to see so many MCC colleagues and @SDSU Partners! #PrideMonth #VamosWave
Josh Demb retweeted
Most viewed in the last 7 days from @JAMANetworkOpen:
In pts w/ early-onset colorectal cancer (EOCRC), what are the most common presenting signs & symptoms, what is their association with EOCRC risk, & what is the time from presentation to diagnosis?
ja.ma/4aPp98c
Josh Demb retweeted
Just released:
Narly half of individuals with EOCRC presented with hematochezia and abdominal pain and one-quarter presented with altered bowel habits. Delays in diagnosis of 4 to 6 months from time of initial presentation.
@IBSAL_IIS @JAMANetworkOpen
jamanetwork.com/journals/jam…
Josh Demb retweeted
Meta-analysis: Nearly half of individuals with early-onset colorectal cancer presented with hematochezia & abdominal pain; 1/4 presented with altered bowel habits. Delays in diagnosis of 4-6 months from time of initial presentation were common. ja.ma/4bP6Yjz
Josh Demb retweeted
Rectal bleeding is associated with a fivefold increased risk of #ColorectalCancer, according to new findings from a study conducted by #FightCRC's #EOCRC Working Group. The study, led by @dembj13 (@UCSDHealthSci) and @JenKolbMD (@LosAngelesVA), has been published in the @JAMANetworkOpen and featured in the @nytimes.
Key findings of the study include:
▶ The most common presenting symptoms among individuals with EOCRC were blood in the stool (45%), abdominal pain (40%), and change in bowel habits (altered bowel habits) (27%).
▶ Blood in the stool and abdominal pain were associated with a significantly higher risk of EOCRC.
▶ On average, it takes four to six months for younger adults to receive a diagnosis after first going to a caregiver with a complaint about a symptom.
nytimes.com/2024/05/24/healt…
Josh Demb retweeted
🚨 Research News! 🚨 #FightCRC's Early Onset Working Group has just published significant findings in @JAMANetworkOpen.
Congratulations to co-author and researcher @JenKolbMD for spearheading the research aimed to report the frequency of presenting signs and symptoms among individuals with #EOCRC, the association of symptoms with #EOCRC risk, and the time to diagnosis.
jamanetwork.com/journals/jam…
Josh Demb retweeted
🚨 New Research Alert! Our latest study, published in @JAMANetworkOpen, emphasizes the critical need for early recognition of red flag symptoms in diagnosing and treating #EOCRC effectively. Read the full publication here:
jamanetwork.com/journals/jam…
At #FightCRC, our commitment to combating the rising incidence of #EOCRC globally remains unwavering. We're collaborating with leading researchers to delve into the underlying causes and develop strategies for prevention, treatment, and support for patients and their families.
Josh Demb retweeted
For many people, a blood test for #colorectalcancer screening is an answered prayer!
A 🩸 test has the potential improve CRC screening to the elusive 80% goal!
Proud to have contributed to this novel tool alongside great colleagues and look forward to the journey ahead.
In a cohort at average risk for colorectal cancer, a cell-free DNA blood-based test had 83% sensitivity for colorectal cancer, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions. Full ECLIPSE study results: nej.md/3v0J319
Grateful for a team that radiates warmth and cheer at our center's winter gathering! Missing some amazing members but sending holiday wishes to all our friends and collaborators! Thankful for your efforts in advancing health equity❄️✨
Josh Demb retweeted
Diagnostic test completion for early age-onset #colorectalcancer is low among U.S. #veterans presenting with iron-deficiency #anemia or #hematochezia.
Women 👩🏻, Black 👨🏿 and Hispanic 👨🏽 veterans less likely to undergo follow-up testing, @dembj13 reported.
bit.ly/46JkHWb
Josh Demb retweeted
Cassandra Fritz, MD, MPHS, Assistant Professor @cfritzmd #WUDeptMedicine Divisions of @WUGastro and General Medicine is one of six inaugural fellows selected for the @JAMANetworkOpen Editorial Fellowship program. @WUSTLmed
Learn more > l8r.it/H559
Josh Demb retweeted
Ended this long week by walking @ZEROCancer 5k this morning with @UCSDHealthCHEER in support of prostrate cancer patients and families.
Josh Demb retweeted
In the 📕#RedJournal:
Risk of Incident and Fatal Colorectal Cancer After Young-Onset Adenoma Diagnosis: A National Cohort Study
Casey and Demb, et al.
👉 bit.ly/48qgZ6a
@dembj13 @smahatamd @ShailjaShahMD @samirguptaGI
Josh Demb retweeted
Honored to have presented our work on disparities in endoscopy referral rates at @DDWMeeting. @samirguptaGI @dembj13 @drfolamay @gopal_srila #DDW2023
Josh Demb retweeted
It's PhD application season! One question I get a lot is, "should I reach out to faculty with whom I'm interested in working?" My answer (but not everybody's) is generally yes.
Big caveat: the faculty you reach out to may not respond, or may not have time to meet. That's okay.
Josh Demb retweeted
Wonder why Traditional Serrated Adenomas require surveillance after 3 years? Our paper in @AGA_CGH demonstrates TSAs confer increased risk for CRC vs normal colonoscopy with CRC rates similar to advanced adenomas, check out below! @samirguptaGI @dembj13
cghjournal.org/article/S1542…
Josh Demb retweeted
It’s the final week of #NationalHispanicHeritageMonth! Get to know @mateopbanegas, PhD, MPH, @UCSDMedSchool @UCSDRadMed assoc prof, co-director of CHEER + @UCSDCancer Cancer Control Program member. Pero cuidado: trust “chile”, not “chili”! #LatinxinAcademia #HealthEquityNow
































